Immunome, Inc. (IMNM) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 594.31M | 660.78M | 279.92M | 277.43M | 323.13M | 221.34M | 244.04M | 284.28M | 313.33M | 144.7M | 91.41M | 39.53M |
| Cash & Short-Term Investments | 582.69M | 653.48M | 272.64M | 268.04M | 317.32M | 217.3M | 240.13M | 278.35M | 309.71M | 138.14M | 90.64M | 38.42M |
| Cash Only | 582.69M | 653.48M | 272.64M | 143.88M | 257.61M | 143.35M | 155.57M | 165.33M | 269.72M | 98.68M | 90.64M | 38.42M |
| Short-Term Investments | 0 | 0 | 0 | 124.16M | 59.71M | 73.95M | 84.56M | 113.02M | 39.98M | 39.46M | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 289K | 0 | 208K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | 6.95 | - | 10.98 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -208K |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 11.62M | 7.29M | 7.29M | 9.4M | 5.81M | 4.04M | 3.91M | 5.93M | 3.62M | 4.27M | 0 | 1.11M |
| Total Non-Current Assets | 25.48M | 22.41M | 19.45M | 18.86M | 19.56M | 18.9M | 12.86M | 11.93M | 6.43M | 3.84M | 1.75M | 1.91M |
| Property, Plant & Equipment | 19.91M | 17.61M | 14.69M | 14.29M | 15.12M | 14.39M | 9.56M | 8.62M | 5.76M | 3.64M | 1.52M | 1.38M |
| Fixed Asset Turnover | - | - | - | 0.27x | 0.20x | 0.23x | 0.32x | 0.33x | 0.22x | 1.48x | 2.46x | 3.38x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 210K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100K |
| Other Non-Current Assets | 5.57M | 4.59M | 4.76M | 4.56M | 4.45M | 4.51M | 3.3M | 3.31M | 668K | 200K | 230K | 432K |
| Total Assets | 619.79M | 683.19M | 299.38M | 296.29M | 342.69M | 240.24M | 256.9M | 296.21M | 319.75M | 148.54M | 93.16M | 41.44M |
| Asset Turnover | - | - | - | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.03x | 0.05x | 0.10x |
| Asset Growth % | 80.86% | 184.38% | 16.54% | 0.03% | 7.17% | 61.73% | 175.76% | 614.89% | 564.58% | 517.73% | 204.99% | 6.19% |
| Total Current Liabilities | 27.41M | 44.99M | 31.45M | 22.88M | 30.8M | 54.31M | 39.53M | 39.9M | 30.77M | 21.83M | 23.11M | 26.39M |
| Accounts Payable | 5.53M | 3.34M | 6.15M | 4.66M | 9.13M | 14.19M | 3.52M | 7.05M | 7.18M | 3.31M | 2.79M | 3.7M |
| Days Payables Outstanding | 530.26 | - | 10.11 | 871.2 | - | - | - | - | - | - | 1.8K | 55.79 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 4.01M | 6.94M | 9.68M | 12.59M | 12.74M | 10.49M | 16.96M | 17.67M |
| Other Current Liabilities | 21.88M | 41.65M | 25.3M | 6.82M | 4.2M | 8M | 5.13M | 4.1M | 2.57M | 4.9M | 1.91M | 907K |
| Current Ratio | 21.68x | 14.69x | 8.90x | 12.13x | 10.49x | 4.08x | 6.17x | 7.12x | 10.18x | 6.63x | 3.96x | 1.50x |
| Quick Ratio | 21.68x | 14.69x | 8.90x | 12.13x | 10.49x | 4.08x | 6.17x | 7.12x | 10.18x | 6.63x | 3.96x | 1.51x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.69M | 3.85M | 4.01M | 4.14M | 4.77M | 4.77M | 2.46M | 2.48M | 3.41M | 6.83M | 63.97M | 5.71M |
| Long-Term Debt | 3.69M | 3.85M | 4.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 4.14M | 4.77M | 4.77M | 2.46M | 2.48M | 1.21M | 1.34M | 122K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 61M | 0 |
| Total Liabilities | 31.11M | 48.84M | 35.46M | 27.02M | 35.57M | 59.08M | 41.99M | 42.38M | 34.18M | 28.66M | 87.08M | 32.1M |
| Total Debt | 3.69M | 3.85M | 4.01M | 4.14M | 4.77M | 4.83M | 2.72M | 2.77M | 1.63M | 1.65M | 371K | 489K |
| Net Debt | -579M | -649.63M | -268.63M | -139.73M | -252.84M | -138.52M | -152.85M | -162.56M | -268.1M | -97.03M | -90.27M | -37.93M |
| Debt / Equity | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.03x | 0.01x | 0.01x | 0.01x | 0.01x | 0.06x | 0.05x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 588.69M | 634.34M | 263.92M | 269.27M | 307.13M | 181.16M | 214.91M | 253.84M | 285.57M | 119.88M | 6.08M | 9.34M |
| Equity Growth % | 91.68% | 250.15% | 22.81% | 6.08% | 7.55% | 51.12% | 3436.97% | 2618.33% | 1960.11% | 619.88% | -73.68% | -69.16% |
| Book Value per Share | 5.20 | 7.26 | 3.00 | 3.09 | 3.87 | 2.89 | 3.57 | 4.24 | 27.70 | 5.46 | 0.50 | 0.77 |
| Total Shareholders' Equity | 588.69M | 634.34M | 263.92M | 269.27M | 307.13M | 181.16M | 214.91M | 253.84M | 285.57M | 119.88M | 6.08M | 9.34M |
| Common Stock | 11K | 11K | 9K | 9K | 9K | 6K | 6K | 6K | 6K | 4K | 1K | 1K |
| Retained Earnings | -782M | -728.16M | -658.26M | -600.81M | -557.41M | -515.77M | -435.52M | -388.42M | -352.3M | -222.81M | -130.17M | -125.83M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | -24K | -3K | 57K | 70K | 2K | 4K | 22K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |